|
UnitedHealth also said Thursday that it will sell part of Ingenix to privately held pharmaceutical support company inVentiv Health Inc. InVentiv Health is buying the i3 clinical development business, including the research, statprobe, and pharmaceutical resourcing units. UnitedHealth said those businesses bring in about $400 million in annual revenue. It did not disclose terms of the sale, which is expected to close in the first half of 2011. With the U.S. economy recovering and health care use declining in 2010, UnitedHealth said its full-year profit grew 21 percent, to $4.63 billion, or $4.10 per share. Its revenue increased 8 percent to $94.16 billion.
[Associated
Press]
Copyright 2011 The Associated Press. All rights reserved. This
material may not be published, broadcast, rewritten or
redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor